ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

GSK Gsk Plc

1,582.50
-7.50 (-0.47%)
Last Updated: 16:15:14
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Gsk Plc LSE:GSK London Ordinary Share GB00BN7SWP63 ORD 31 1/4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -7.50 -0.47% 1,582.50 1,582.00 1,582.50 1,595.50 1,580.00 1,593.00 2,743,314 16:15:14
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 30.33B 4.93B 1.1970 13.22 65.17B
Gsk Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker GSK. The last closing price for Gsk was 1,590p. Over the last year, Gsk shares have traded in a share price range of 1,302.60p to 1,719.80p.

Gsk currently has 4,117,033,438 shares in issue. The market capitalisation of Gsk is £65.17 billion. Gsk has a price to earnings ratio (PE ratio) of 13.22.

Gsk Share Discussion Threads

Showing 16701 to 16724 of 33100 messages
Chat Pages: Latest  676  675  674  673  672  671  670  669  668  667  666  665  Older
DateSubjectAuthorDiscuss
17/2/2018
19:39
Alzheimer's Disease and Prion Protein

Alzheimer's disease (AD) is a devastating neurodegenerative disease with progressive loss of memory and cognitive function, pathologically hallmarked by aggregates of the amyloid-beta (Aβ) peptide and hyperphosphorylated tau in the brain. Aggregation of Aβ under the form of amyloid fibrils has long been considered central to the pathogenesis of AD. However, recent evidence has indicated that soluble Aβ oligomers, rather than insoluble fibrils, are the main neurotoxic species in AD. The cellular prion protein (PrPC) has newly been identified as a cell surface receptor for Aβ oligomers. PrPC is a cell surface glycoprotein that plays a key role in the propagation of prions, proteinaceous infectious agents that replicate by imposing their abnormal conformation to PrPC molecules. In AD, PrPC acts to transduce the neurotoxic signals arising from Aβ oligomers, leading to synaptic failure and cognitive impairment. Interestingly, accumulating evidence has also shown that aggregated Aβ or tau possesses prion-like activity, a property that would allow them to spread throughout the brain. In this article, we review recent findings regarding the function of PrPC and its role in AD, and discuss potential therapeutic implications of PrPC-based approaches in the treatment of AD.

buywell3
17/2/2018
10:35
On the day ex div, a nice positive rns and the shares won't fall by the ex div amount of 23p next week.
montyhedge
16/2/2018
18:05
At the present level this is great value so I've added another 1000 shares to my bucket.
chessman2
16/2/2018
16:38
This time the turnaround could be for real! Anyway happy to collect the quarterly divi, over 6% pa, better than down at el banco
ny boy
16/2/2018
16:31
Yes,for investors who are new to GSK it would be a good opportunity to pick up shares at bargain prices on ex- div day.!
abdullla
16/2/2018
16:12
Like I said 1355p before ex dividend next week. I have seen GSK go ex 19p but gone up.
Could it happen again.

montyhedge
16/2/2018
13:31
It is possible Warren Buffet has made buying pharma stocks acceptable again?
romeike
16/2/2018
09:32
SP looking perkier this morning!
ygor705
16/2/2018
08:05
Should have a run up to ex div next week 1355p, div 23p of course, but I don't think it will fall that amount, probable 15p.
montyhedge
15/2/2018
16:03
Finger crossing didn't work,but you can't say we didn't try,back to the future or shall I say past !
abdullla
15/2/2018
13:55
Maybe if we all cross our fingers we can finish up over £13.
romeike
15/2/2018
12:41
Monty - did you red tick me? You will remember from my post that there are some strange things around Lupuzor.
alphorn
15/2/2018
12:20
Nice 23p dividend for this quarter in the bag, ex div next week.
montyhedge
15/2/2018
12:18
I think IMM will flop shareprice telling you that, no competition for GSK I reckon.
montyhedge
15/2/2018
10:01
No news yet from IMM on Lupuzor.
alphorn
15/2/2018
09:57
I understand that Merck's Consumer Healthcare may also be up for grabs ......
tradermichael
15/2/2018
09:43
I hope we win, easily raise money in the bond market, dividend safe in my view.
montyhedge
15/2/2018
09:41
I think next week. Bids had to be in 1st Feb, think there was only two. Lol it's either yes or know.
montyhedge
15/2/2018
09:37
LOL ..first of many
badtime
15/2/2018
09:16
Until then the GSK share price will bleed but slowly !
abdullla
15/2/2018
09:10
For Pfizer Consumer Healthcare, there is the possibility of a deal to be finalized by mid-year, 2018.
tradermichael
15/2/2018
09:02
back in again . Techs still saying BUY
juju44
15/2/2018
08:59
Hi Monty - when do you think this will be?
bilster1
15/2/2018
08:49
Should be hearing about the bid shortly.
montyhedge
Chat Pages: Latest  676  675  674  673  672  671  670  669  668  667  666  665  Older

Your Recent History

Delayed Upgrade Clock